INS and Hypoglycemia: Owing to the increased accessibility to anti-diabetic advancements such as insulin analogs, continuous subcutaneous insulin infusion, and continuous glucose monitoring devices that improve glycemic control with minimal effect on increasing the risk of hypoglycemia in children, there is a trend for establishing stringent glycemic control goals in recent international guidelines (32, 33).